A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Guérin in patients with non-muscle invasive bladder carcinoma: A retrospective study

Intravesical Bacillus Calmette Guerin (BCG) is the gold standard therapy for intermediate/high-risk non-muscle invasive bladder cancer (NMIBC). However, the response rate is ~60%, and 50% of non-responders will progress to muscle-invasive disease. BCG induces massive local infiltration of inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales: VILLOLDO, GUSTAVO MARTÍN, POMBO, MARÍA TERESA, ARIS, MARIANA, CHEMI, JOAQUÍN, MANDÓ, PABLO, NAGARAJU, SUPRIYA, CAMEAN, JUAN, BURIONI, ADRIÁN, EGEA, DEBORAH, AMAT, MORA, MELLADO, JOSÉ LEÓN, MORDOH, JOSÉ, VILLARONGA, ALBERTO, BARRIO, MARÍA MARCELA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208021/
https://www.ncbi.nlm.nih.gov/pubmed/37304240
http://dx.doi.org/10.32604/or.2023.028163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208021/
https://www.ncbi.nlm.nih.gov/pubmed/37304240
http://dx.doi.org/10.32604/or.2023.028163

Ejemplares similares